EXAI STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Exscientia plc Class Action
June 05, 2024 16:10 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Exscientia plc's (EXAI) Former CEO's Conduct Violated the Company's Code of Business Conduct
NN, Inc. Executive Management to Present at the Sidoti June Small Cap Investor Conference
June 05, 2024 16:10 ET
|
NN, Inc.
CHARLOTTE, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies,...
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
June 05, 2024 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
Globus Maritime Sets Date For the Release of First Quarter 2024 Results
June 05, 2024 16:08 ET
|
Globus Maritime Limited
GLYFADA, Greece, June 05, 2024 (GLOBE NEWSWIRE) -- Globus Maritime Limited (the “Company” or “Globus”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that it will release financial...
GDRX STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the GoodRx Holdings, Inc. Class Action
June 05, 2024 16:06 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that GoodRx Holdings, Inc. (GDRX) Misrepresented its Business Prospects
Greif Reports Fiscal Second Quarter 2024 Results
June 05, 2024 16:05 ET
|
Greif Inc
DELAWARE, Ohio, June 05, 2024 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today announced fiscal second quarter 2024 results. ...
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
June 05, 2024 16:05 ET
|
Relay Therapeutics, Inc.
CAMBRIDGE, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
June 05, 2024 16:05 ET
|
PowerUp Acquisition Corp.
New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that, on June 3, 2024, the Company received a notice (the “Notice”) from the...
QIAGEN führt Assay-Design-Tool für digitale PCR Plattform QIAcuity ein und erweitert Anpassungsmöglichkeiten in Forschungsplattform GeneGlobe
June 05, 2024 16:05 ET
|
QIAGEN N.V.
VENLO, Niederlande, June 05, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Einführung seines neuen digitalen PCR (dPCR) Custom Assay Design Tools für die...